Zou, Xinrong
Nagino, Ken
Okumura, Yuichi
Midorikawa-Inomata, Akie
Eguchi, Atsuko
Yee, Alan
Fujimoto, Keiichi
Miura, Maria
Sung, Jaemyoung
Huang, Tianxiang
Fujio, Kenta
Akasaki, Yasutsugu
Nakao, Shintaro
Kobayashi, Hiroyuki
Inomata, Takenori
Funding for this research was provided by:
Japan Society for the Promotion of Science (21K17311, 22K16983, 20KK0207)
Article History
Received: 28 October 2023
Accepted: 22 February 2024
First Online: 26 February 2024
Competing interests
: K.N., Y.O., and A.M.I. received personal fees from InnoJin, Inc., outside the submitted work. S.N. received grants from Kowa Co., Ltd., Mitsubishi Tanabe Pharma Corp., Alcon Japan, Ltd., Santen Pharmaceutical Co., Ltd., Machida Endoscope Co., Ltd., Wakamoto Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Senju Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., Hoya Corp., and Novartis Pharma K.K. T.I. received grants from Johnson & Johnson Vision Care, Inc., SEED Co., Ltd., Novartis Pharma K.K., and Kowa Company, Ltd., outside the submitted work, as well as personal fees from Santen Pharmaceutical Co., Ltd. and InnoJin, Inc. The remaining authors declare no competing interests.